Skip to main content

Study M572

Study name

Wu ZX 2019

Title

Biomarker screening for antenatal depression in women who underwent caesarean section: a matched observational study with plasma lipidomics

Overall design

The aim of this study was to use lipidomics to identify potential biomarkers related to antenatal depression in women who have undergone caesarean section. A total of 66 subjects were recruited, including 33 subjects with major antenatal depression (major antenatal depression group) and 33 matched controls without antenatal depression (control group). Lipidomics of the plasma samples were performed using Ultra Performance Liquid Chromatography-mass spectrometry analysis to explore the differentially expressed lipids in women with or without antenatal depression.

Study Type

Type1;

Data available

Unavailable

Organism

Human;

Categories of depression

Depressive disorder; Antenatal depressive disorder; Antenatal depressive disorder;

Criteria for depression

DSM-V diagnosed major depression

Sample size

66

Tissue

Peripheral; Blood; Plasma;

Platform

MS-based; LC-MS: HESI-II with Thermo Scientific Q Exactive hybrid quadruple Orbitrap mass spectrometer (Thermo Fisher Scientific, Waltham, MA, USA);

PMID

31455267

DOI

10.1186/s12888-019-2241-1

Citation

Wu Z, Zhao P, Long Z, et al. Biomarker screening for antenatal depression in women who underwent caesarean section: a matched observational study with plasma lipidomics. BMC Psychiatry. 2019;19(1):259.

Metabolite

5-Aminopentanoic acid;

SM(d18:1/16:0);

LysoPE(0:0/18:2(9Z,12Z));

LysoPC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0);

LysoPC(20:3/0:0);

SM(d16:1/18:0);

9Z-Heptatriacontene;

LysoPC(16:0/0:0);

EB 1213;

3alpha-Hydroxy-7-oxo-5alpha-cholan-24-oic Acid;

Cholesterol sulfate;

PC(18:2(2E,4E)/0:0);

LMST03020057;

LysoPC(0:0/18:0);

1-Hexanol;

PE(13:0/22:1(11Z));

1,25-Dihydroxy-23-oxo-vitamin D3;

SM(d16:1/16:0);

Undecanoic acid;

SM(d18:1/15:0);

Sorbitan stearate;

SM(d16:1/20:1);

PC(18:1(9Z)/0:0);

PE(8:0/8:0);

Etretinate;

13-amino-tridecanoic acid;

6-deoxyerythronolide B;

PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z));

(7Z,10Z)-hexadecadienoylcarnitine;

12-amino-dodecanoic acid;

5-((5Z,8Z,11Z,14Z)-heptadeca-5,8,11,14-tetraen-1-yl)resorcinol;

MG(0:0/18:1(9Z)/0:0);

8-methoxy-13-hydroxy-9,11-octadecadienoic acid;

1-Heptene;